The γδ T cells are innate-like T cells and are an important source of interleukin (IL)-17A in mucosal tissues such as the lung. 1 The frequency of γδ T cells among lymphocytes circulating in the blood and lymphoid organs is estimated at o5%. 1 However, γδ T cells are more abundant in mucosal tissues, such as the gut, skin and lung. [2] [3] [4] [5] During development, a subset of γδ T cells differentiates in the thymus to produce IL-17A (γδT17). 6 These γδT17 cells are maintained in the secondary lymphoid organs and mucosal tissues. 7, 8 γδT17 cells perform a variety of immunologic functions in vivo. They are an early source of IL-17A to recruit neutrophils. 9, 10 In many bacterial and fungal infections, γδ T cells have a protective role in controlling infection. 1, 11, 12 Conversely, they have been found to be pathogenic in animal models of autoimmune diseases and in solid organ transplantation. [13] [14] [15] [16] In an orthotopic left lung transplant mouse model, we previously found that γδT17 cells expand in response to lung transplantation and are an important source of IL-17A. 17 However, less is known about the maintenance and expansion of γδT17 cells in the periphery at steady state.
The γδT17 cells share a cytokine profile with IL-17A-producing CD4 + T cells (T-helper 17, Th17) but have clear distinction in generation and maintenance. 18 Spontaneous development in the thymus and peripheral maintenance of γδT17 cells has been suggested to be dependent on transforming growth factor-β1 (TGFβ1) and does not require IL-6, whereas Th17 cells differentiate in the periphery after antigen recognition in the presence of TGFβ1 and IL-6, among other cytokines. 8, [19] [20] [21] The γδT17 cells require intact Hes1/Notch signaling, and not signal transducer and activator of transcription 3 (STAT3), for their development and maintenance. 22 In addition, γδT17 cells may respond earlier than Th17 cells during an immune response. 13 Despite these differences, γδT17 cells and Th17 cells have been found to regulate each other. Previous work suggested Th17 cells promoted the homeostatic maintenance of γδT17 cells in a TGFβ1-dependent manner. 8 Further, γδT17 cells have been found to support the generation and amplification of Th17 cells in vitro and in vivo during inflammation. 13 Although these studies have suggested that Th17 and γδ T cells influence the expansion of each other in the periphery, the mechanisms are not clear.
Recently, we found that CD4 + T-cell depletion after lung transplant decreased the expansion of γδT17 cells in the transplanted lungs compared with controls after transplant. 17 On the other hand, we found that γδT17 cell responses were not diminished in transplanted lungs or secondary lymphoid organs in the absence of Th17 cells after lung transplant. 17 These findings were unexpected given the previous work, suggesting that Th17 cells had a role in the maintenance of γδT17. 8 However, the lung transplant model represents a chronic inflammatory state and the regulation of γδT17 cells may be different during homeostatic conditions. In the current study, we investigated the population of γδT17 cells in the absence of Th17 cells under homeostatic conditions and the ability of Th17 cells and TGFβ1 to affect γδT17 cells in the peripheral lymphoid tissues and lung in the absence of inflammation.
RESULTS
γδT17 cells are not affected by the absence of Th17 cells in STAT3 CD4 − / − mice STAT3 is a transcription factor required for differentiation of naïve CD4 + T cells into Th17 effector cells. 23 Mice that lack STAT3 in CD4 + T cells (STAT3 CD4 − / − ) are not able to generate Th17 cells in vitro or in vivo. 23, 24 We have previously found that the frequency of IL-17A + γδ T cells among γδ T cells in the transplanted lung and mediastinal lymph nodes (LNs) in STAT3 CD4 − / − recipients is similar to controls (data reproduced in Supplementary Figures S1A and B ). 17 These findings suggested Th17 cells were dispensable for the maintenance of peripheral γδT17 cells. 8 However, the transplant model represents an inflammatory condition, which may underlie the differences. Therefore, we investigated the requirement of Th17 cells in the homeostatic maintenance of γδT17 cells in unmanipulated STAT3 CD4 − / − mice. Interestingly, we found that the frequency of γδT17 cells was not decreased in unmanipulated STAT3 CD4 − / − mice and was similar to controls (Figures 1a and b ). There was also no significant reduction in the absolute number of γδT17 cells in the lungs, spleen, inguinal LN or thymus of STAT3 CD4 − / − mice ( Figure 1b ). As previously reported, we also confirmed that CD4 + T cells in STAT3 CD4 − / − mice do not differentiate into Th17 cells in vivo (Supplementary Figure S2 ). 24 Moreover, unmanipulated STAT3 CD4 − / − mice do not have any defect in the overall frequency and absolute number of total γδ T cells in the lungs, spleen, inguinal LN or thymus ( Supplementary Figures S3A  and B ). These findings suggested that Th17 cells were not absolutely required for the peripheral maintenance of γδT17 cells.
STAT3-deficient CD4 T cells produce TGFβ1 under Th17 polarizing conditions
TGFβ1 has a key role in the regulation of Th17 and T-regulatory cells. 25, 26 In addition, maintenance of γδT17 cells by Th17 cells was previously suggested to be TGFβ1 dependent. 8, 27 We hypothesized that STAT3 CD4 − / − T cells may be capable of producing TGFβ1 under Th17 differentiation conditions and maintain γδT17 cells in STAT3 CD4 − / − mice. To test our hypothesis, naive CD4 + T cells from STAT3 CD4 − / − mice were stimulated in vitro under Th17 differentiation conditions for 3 days, washed and then restimulated, to determine the production of TGFβ1. As expected, STAT3 CD4 − / − T cells do not produce IL-17A in vitro (Figure 2a ). 23 However, we found that the mRNA expression of TGFβ1 was increased in STAT3-deficient CD4 + T cells as compared with littermate control T cells ( Figure 2b ). In addition, the culture supernatants from STAT3 CD4 − / − T cells had significantly higher TGFβ-1 levels as compared with controls γδT17 maintenance is independent of Th17 PK Gupta et al ( Figure 2b ). Thus, STAT3 is not required for the expression of TGFβ1 in CD4 + T cells. Our data suggest STAT3 expression may directly or indirectly negatively regulate TGFβ1 expression during Th17 differentiation.
CD4 + T cells do not restore γδT17 cells but promote expansion of IFN-γ + γδ T cells in vivo
Based on our findings in Figure 2 , it was possible that TGFβ1 produced by STAT3-deficient CD4 + T cells was sufficient for the maintenance of γδT17 cells in the STAT3 CD4 − / − mice. Previous work in TCRβ − / − mice, which have a defect in γδT17 cells, had found that adoptive transfer of CD4 + T cells or Th17 cells expanded the pool of γδT17 cells and expansion was dependent on TGFβ1. 8 As previously shown, TCRβ − / − mice have a defect in γδT17 cells in the lymphoid tissues but an increase in the overall numbers of γδ T cells in the absence of other T cells ( Figure 3a and data not shown). 8 The decrease in the proportion of γδT17 cells was not restricted to lymphoid tissues, as we also found a marked decrease in the lungs (Figure 3a ). To determine the ability of Th17 to affect the γδT17 cell population, we adoptively transferred in vitro differentiated Th17 cells from wild-type mice into TCRβ − / − mice. However, we found that the transfer of Th17 cells in our hands did not expand the frequency of γδT17 cells in TCRβ − / − mice and actually decreased their frequency in the lung and lymphoid tissues (Figures 3a and b ). As naive CD4 + T cells have also been found to promote expansion of γδT17 cells, we determined whether these T cells would be more effective. We also did not find any significant increase in the frequency of γδT17 cells with the transfer of naive CD4 T cells, although there was a small increase in the total number (Figures 3a and b and data not shown). The results were not due to a lack of Th17 cells homing to secondary lymphoid tissue or the lungs, as IL-17A-producing CD4 + T cells were found after transfer of either Th17 cells or naive CD4 + T cells (Supplementary Figure S4 ). Unexpectedly, transfer of Th17 cells or naive CD4 + T cells into TCRβ − / − mice preferentially expanded the frequency of interferon-γ (IFNγ)-producing γδ T cells (Figures 3a and b ). The increase was particularly pronounced in the lungs with a marginal effect on the spleen and inguinal LNs ( Figure 3 ). In addition, the absolute number of lung γδ T cells was significantly higher after transfer of T cells into TCRβ − / − mice (Figure 3c ). Interestingly, the lymphoid tissues had little expansion of the overall numbers of γδ T cells with the exception of Th17 cells affecting the numbers of γδ T cells in the inguinal LN ( Figure 3c ). This result was correlated with an increase in CD4 + T cells in the inguinal LN when Th17 were transferred as opposed to naive CD4 + T cells (Supplementary Figure S4) . These data suggest that IFN-γ + γδ T cells are preferentially expanding after adoptive transfer of CD4+ T cells into TCRβ − / − mice with expansion most pronounced in the lung.
TGFβ1 is not necessary for γδT17 cell homeostasis Although our data suggested Th17 cells could not expand the deficient pool of γδT17 cells in TCRβ − / − mice, it was still possible that TGFβ1 was important for the maintenance of γδT17 cells in vivo. Furthermore, the significance of the elevated TGFβ1 found in vitro from STAT3 CD4 − / − T cells was not clear. To determine the role of TGFβ1 activity in vivo, we administered neutralizing anti-TGFβ antibody twice weekly for 3 weeks to STAT3 CD4 − / − mice and measured the frequency of γδT17 cells in the lungs and lymphoid tissues. 28 Interestingly, rather than a decrease in the percentage of γδT17 cells among γδ T cells, we found an increase in γδT17 cells in the lungs and inguinal LN compared with control mice, whereas the spleen had no difference ( Figure 4 ). There was no increase in the frequency of IFNγ + γδ T cells among the γδ T cells (Figure 4 and data not shown). These results suggested TGFβ1 suppressed the expansion or differentiation of peripheral γδT17 cells.
To further investigate these findings, we determined the effects of TGFβ1 on γδT17 cells enriched in vitro using IL-7. IL-7 has previously been found to promote expansion of γδT17 cells in vivo and in vitro. 29 In the presence of IL-7, we found that the majority of LN-derived γδ T cells were γδT17 after 72 h and their number was significantly increased compared with ex vivo or culturing in media alone ( Figure 5 ). These results are similar to prior work. 29 Unexpectedly, blockade of TGFβ1 with the same neutralizing antibody we used in vivo had minimal effect on the frequency and number of γδT17 cells expanding in response to IL-7 (Figures 5a and b) . It was possible that the concentration of TGFβ1 in the media was lower than the threshold to affect γδT17 cells, or that γδT17 cells were not expressing TGFβ1 receptors. However, the type II receptor for TGFβ, TGFβRII, was expressed ex vivo and in vitro after expansion with IL-7 ( Figure 5c ). 19 To investigate further the response of γδT17 cells to TGFβ1, we cultured LN cells with exogenous TGFβ1 in the presence of IL-7. We found that TGFβ1 at 1 ng ml − 1 significantly suppressed the recovery of all γδ T cells and γδT17 cells in response to IL-7 (Figures 5d and e ). However, the majority of the γδ T cells in the cultures remained IL-17A producing (Figure 5f ). Increasing concentrations of TGFβ1 did not have any further effect on decreasing γδT17 cells (data not shown). Exogenous TGFβ1 also decreased the survival of γδT17 cells cultured without IL-7 (data not shown). Our data suggest that TGFβ1 may be negatively regulating peripheral γδT17 cells in vivo and in vitro by directly inhibiting their survival and expansion rather than affecting differentiation. γδT17 maintenance is independent of Th17 PK Gupta et al
DISCUSSION
In the current study, we have found that the pool of peripheral γδT17 cells is maintained in mice that have defective Th17 differentiation. The effect was true for secondary lymphoid tissues, as well as the lung.
We have also found that Th17 cells generated in vitro produce TGFβ1 and STAT3 deficiency is associated with increased TGFβ1 production. Despite the ability of Th17 cells to be a source of TGFβ1 in vitro, adoptive transfer of these T cells failed to restore γδT17 cell populations in TCRβ − / − mice. Similarly, adoptive transfer of naive CD4 T cells was also not effective to expand γδT17 cells. Surprisingly, transferred Th17 cells or naive CD4 T cells preferentially expanded IFN-γ + γδ T cells and the total number of γδ T cells in TCRβ − / − mice. The effect was most pronounced in the lungs, suggesting the effect may be tissue specific. Furthermore, TGFβ1 neutralization in vivo expanded rather than decreased the pool of γδT17 cells in the lungs or lymphoid tissues compared with controls. In support of these findings, exogenous TGFβ1 decreased IL-7-induced γδT17 cell expansion in vitro. The γδT17 cells expressed TGFβRII in vitro, which suggests direct inhibition by TGFβ1. Together, our data suggest that Th17 cells are not required to maintain γδT17 cells. Our data also do not support a requirement for TGFβ1 for γδT17 cell homeostasis in the periphery of adult mice and suggest TGFβ1 may negatively regulate γδT17 cells in mucosal tissues. Our data are consistent with the findings by Haas et al. 30 that γδT17 cells develop before birth and are self-renewing. The lack of effect of Th17 cells or naive CD4 + T cells on γδT17 cell expansion, when γδT17 cells development was limited in TCRβ − / − mice, suggests that γδT17 cells may have limited responsiveness to CD4 + T-cell-derived direct or indirect signals postnatally at steady state. These T cells may still respond under inflammatory conditions. However, we did find that CD4 + T cells, regardless of differentiation to Th17 or naive, affected the pool of IFN-γ + γδ T cells and the effect was most consistent for the lung. Whether IFN-γ + γδ T cells are preferentially expanding or the IFN-γ -ve γδ T cells differentiate into IFN-γproducing cells is not entirely clear. It is likely to be that there is a preferential expansion of IFN-γ + γδ T cells, because the number of IFN-γ -ve γδ T cells did not signficantly change (data not shown). The lung-specific effect may be related to the lung microbiota or mucosal environment influencing T-cell trafficking or differentiation. Alternatively, the lung may provide an ideal site for the two T-cell subsets to interact with each other. The mechanisms by which CD4 + T cells expand IFN-γ + γδ T cells remain to be determined in future studies.
Although our data suggest there are differences in the responsiveness of γδ T cells to homeostatic signals from CD4 + T cells, the results contrast with a study suggesting that Th17 cells and naive CD4 + T cells expanded γδT17 cells in TCRβ-deficient mice. 8 We have used mice on the C57Bl/6N background for collecting of CD4 + T cells for adoptive transfer, whereas the previous study used C57Bl/6J mice. There are several known genetic polymorphisms that exist between these strains. 31 It is also possible that differences in the microbiota may impact IL-17A production from γδ T cells under homeostatic conditions. 32 As we still found IL-17A-producing CD4 + T cells after adoptive transfer, we do not think it was a defect in the survival or persistence of the transferred Th17 cells leading to decreased effectiveness. Nevertheless, we cannot rule out that differences in genetic background or microbiota affected the ability of the transferred T cells to expand the γδT17 cells. Taken together, our data suggest that Th17 cells are variable in the ability to promote expansion of γδT17 cells in vivo.
TGFβ1 had previously been found to be critical for the development of γδT17 cells and was suggested to have a role in the maintenance of γδT17 cells in the periphery. 8, 19 We have found that Th17 cells produced TGFβ1 after differentiation in vitro and STAT3 deficiency was associated with an increase in TGFβ1 production and expression. Deficiency of STAT3 in Foxp3 + T cells was also found to increase the level of TGFβ1 produced by T-regulatory cells. 33 Our data suggested in vivo STAT3-deficient CD4 + T cells may be producing increased levels of TGFβ1. However, we did not find an increase in γδT17 cells at baseline in STAT3 CD4 − / − mice. Further, we found that in vivo TGFβ1 neutralization increased rather than decreased the population of lung and inguinal LN γδT17 cells in STAT3 CD4 − / − mice, but had no effect in the spleen. The pool of γδT17 cells is small in the spleen and they may not be easily expanded. These results suggest that γδT17 cells are heterogeneous in their response to cytokine stimulation depending on their anatomical location and may be dependent on other signals such as microbial stimulation. We did not see an enhanced cytokine response from non-γδ T cells with TGFβ1 neutralization to suggest widsepread effects on all T cells. Supporting our in vivo findings, exogenous TGFβ1 reduced the numbers of γδT17 cells expanded in response to IL-7 in vitro. These γδT17 cells expressed TGFβ RII ex vivo and after culture with IL-7, suggesting that TGFβ1 directly inhibited γδT17 cell survival or proliferation. Even in the absence of IL-7, TGFβ1 negatively affected recovery of γδT17 cells in cultures of LN cells when compared with media alone. Overall, these data suggest that TGFβ1 is not required for persistence of γδT17 cells and TGFβ1 may normally restrain the pool of γδT17 cells. Future work will need to understand the relevant sources of TGFβ1 in vivo. From our studies it appears that unstimulated LN CD4 + T cells are not sufficient to produce enough TGFβ1 to suppress γδT17 cells in vitro.
In conclusion, our data suggest that Th17 cells are not necessary for the maintenance of γδT17 cells after development and are not sufficient to expand pre-existing γδT17 cells. Furthermore, in vivo and in vitro γδT17 cell persistence at steady state is not dependent on TGFβ1. In contrast, we found that TGFβ1 inhibited the expansion of γδT17 cells in vitro and may negatively regulate γδT17 cell expansion or survival in the lungs. These data suggest that the factors promoting maintenance of γδT17 cells are distinct from those required for development. Interestingly, in our studies CD4 + T cells expanded IFN-γ + γδ T cells, while having no effect on γδT17 cells, and preferentially affected the lung rather than lymphoid tissues. CD4 + T cells and TGFβ1 may regulate γδ T cells in a context-dependent manner. A better understanding of this regulation may provide effective therapeutic targets for promoting immunity to infections and tumors and for treating autoimmune diseases and transplant rejection.
METHODS Animals
C57BL/6N.Stat3 fl/fl .CD4-Cre (STAT3 CD4 − / − ) mice and littermate controls were previously described and bred in-house. 23 TCRβ − / − , C57BL/10 and C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) or Envigo (Indianapolis, IN, USA). Mice between the ages of 2 and 3 months were used in the study. Mice were housed under specific pathogenfree conditions in the animal care facility at the University of Illinois at Chicago. All experimental animal protocols in this study were reviewed and approved by the Institutional Animal Care and Use Committee of University of Illinois at Chicago.
Tissue preparation
Spleen, inguinal LN and thymus were collected and dissociated mechanically. Lung tissue was digested with Collagenase I (Life Technologies, Carlsbad, CA, USA) for 30 min at 37°C. Single-cell suspensions were treated with red blood cell lysis buffer (BioLegend, San Diego, CA, USA).
Flow cytometry
Single-cell suspensions were stained with antibodies for CD4 (GK1.5), γδ TCR (GL3), IL-17A (TC11-18H10.1), IFN-γ (XMG1.2) (Biolegend) and TGFβRII (R&D Systems, Minneapolis, MN, USA). For intracellular staining, cells were restimulated with phorbol 12-myristate 13-acetate (100 ng ml − 1 ) and ionomycin (1 μg ml − 1 ) for 4 h and Brefeldin A (10 μg ml − 1 ) was added for the last 3 h. Cells were stained with fixable Live/Dead stain (Invitrogen, Eugene, OR, USA) followed by staining of surface markers, fixed with formaldehyde, permeabilized and stained for intracellular cytokines. Acquisition was performed on a LSR Fortessa (BD Biosciences, San Jose, CA, USA) and data analysis was performed with Flowjo software (Tree Star, Ashland, OR, USA).
In vitro Th17 cell differentiation
Naive CD4 + CD62L + T cells were purified from the spleen and LNs using a commercially available kit (Miltenyi Biotec, San Diego, CA, USA). Naive CD4 T cells (1 × 10 6 ) per well were stimulated with plate bound anti-CD3 (2 μg ml − 1 ) and soluble anti-CD28 (1 μg ml − 1 ) in the presence of TGFβ1 (2 ng ml − 1 ), IL-6 (100 ng ml − 1 ), IL-23 (10 ng ml − 1 ), IL-1β (100 ng ml − 1 ), anti-IFN-γ (10 μg ml − 1 ) and anti-IL-4 (10 μg ml − 1 ) for 3 days. Differentiation of Th17 cells was confirmed by flow cytometry. Antibodies used in Th17 differentiation were purchased from Bio X cell, West Lebanon, NH, USA. All the cytokines except IL-23 (R&D Systems) were procured form Peprotech, Rocky Hill, NJ, USA. TGFβ1 enzyme-linked immunosorbent assay and real-time PCR Differentiated CD4 T cells were restimulated with anti-CD3 (2 μg ml − 1 ) for an additional 24 h in AIM V serum free media (Life Technologies). Culture supernatants were collected and TGFβ1 protein was estimated by enzymelinked immunosorbent assay (R&D Systems). Cells were used to extract total RNA using RNA isolation kit (Qiagen, Valencia, CA, USA). Total RNA was reverse transcribed to cDNA with a qScript cDNA Supermix kit (Quanta Biosciences, Gaithersburg, MD, USA). Real-time PCR was performed using PerfeCTa SYBR Green (Quanta Biosciences) on a CFX Connect Real-time PCR system (Bio-Rad, Hercules, CA, USA). The following primer sequences were used: TGFβ1 (F: 5′-TGACGTCACTGGAGTTGTACGG-3′, R: 5′-GGTTC ATGTCATGGATGGTGC-3′); GAPDH (F: 5′-CATGGCCTTCCGTGTTC CTA-3′, R: 5′-CCTGCTTCACCACCTTCTTGAT-3′) (Integrated DNA Technologies, Coralville, IA, USA).
Adoptive transfer
Th17 cells (5 × 10 6 ) or 3×10 6 naive (CD4 + CD62L + T cells) T cells were injected via retro-orbital venous sinus into TCRβ − / − recipients. At day 14 after transfer, cytokine expression in γδ T cells was investigated in different tissues.
TGFβ neutralization in vivo
Mice were injected intraperitoneally with 500 μg anti-mouse TGFβ1 (1D11, Bio X cell) twice a week. The mice were killed after 3 weeks and the cytokine profile of γδ T cells was investigated by intracellular cytokine staining.
Cell culture
Cells collected from LNs (inguinal, superficial cervical, axillary and mesenteric) were incubated for 72 h with IL-7 (20 ng ml − 1 , Peprotech). Where indicated, TGFβ1 blocking antibody (50 μg ml − 1 ) or TGFβ1 (1, 2, 4 or 8 ng ml − 1 ) were added to the culture. After 72 h, cells were collected for analysis by flow cytometry. 
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). Differences were considered significant at Po0.05. All data are expressed as mean ± (s.e.m.).
